PLx Pharma Inc. Purchase Agreements
13 Contracts & Agreements
- Amendment No. 1 to Asset Purchase Agreement dated May 26, 2023 by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on May 26, 2023)
- Asset Purchase Agreement, dated April 12, 2023, by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on April 12, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on November 16, 2020)
- Purchase Agreement, dated as of March 12, 2020, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on March 13, 2020)
- Purchase Agreement, dated as of December 20, 2018, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on December 21, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)
- ASSET PURCHASE AGREEMENT between DIPEXIUM PHARMACEUTICALS, LLC and THE GENAERA LIQUIDATING TRUST, ARGYCE, LLC, as Trustee Dated April 8, 2010 (Filed With SEC on February 6, 2014)
